Thromboelastography as a Better Indicator of Hypercoagulable State After Injury Than Prothrombin Time or Activated Partial Thromboplastin Time

被引:314
|
作者
Park, Myung S. [1 ]
Martini, Wenjun Z. [1 ]
Dubick, Michael A. [1 ]
Salinas, Jose [1 ]
Butenas, Saulius [2 ]
Kheirabadi, Bijan S. [1 ]
Pusateri, Anthony E. [1 ]
Vos, Jeffrey A. [3 ]
Guymon, Charles H. [1 ]
Wolf, Steven E. [1 ]
Mann, Kenneth G. [2 ]
Holcomb, John B. [1 ]
机构
[1] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA
[2] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA
[3] W Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2009年 / 67卷 / 02期
关键词
Deep vein thrombosis; Pulmonary embolism; Thromboelastograph; RETRACTED ARTICLE. SEE; DEEP-VEIN THROMBOSIS; TISSUE-FACTOR; FACTOR-XI; HYPOTHERMIC COAGULOPATHY; VENOUS THROMBOEMBOLISM; ANTITHROMBIN-III; FACTOR XA; PG; 29067; COAGULATION;
D O I
10.1097/TA.0b013e3181ae6f1c
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To investigate the hemostatic status of critically ill, nonbleeding trauma patients. We hypothesized that a hypercoagulable state exists in patients early after severe injury and that the pattern of clotting and fibrinolysis are similar between burned and nonburn trauma patients. Materials: Patients admitted to the Surgical or burn intensive care unit within 24 hours after injury were enrolled. Blood samples were drawn on days 0 through 7. Laboratory tests included prothrombin time (PT). activated partial thromboplastin time (aPTT), levels of activated factor XI, D-dimer, protein C percent activity, antithrombin III percent activity, and thromboelastography (TEG). Results: Study subjects were enrolled front April 1, 2004, to May 3 1, 2005, and included nonburn trauma patients (n = 33), burned patients (n = 25) and healthy (control) subjects (n = 20). Despite aggressive thromboprophylaxis, three subjects (12 burned and I nonburn trauma patients [6%]) had pulmonary embolism during hospitalization. Compared with controls, all patients had prolonged PT and aPTT (p < 0.05). The rate of clot formation (a angle) and maximal clot strength were higher for patients compared with those of controls (p < 0.05), indicating a hypercoagulable state. Injured patients also had lower protein C and antithrombin III percent activities and higher fibrinogen levels (p < 0.05 for all). Activated factor XI was elevated in 38% of patients (control subjects had undetectable levels). Discussion: Thromboelastography analysis of whole blood showed that patients were in a hypercoagulable state; this was not detected by plasma PT or aPTT. The high incidence of pulmonary embolism indicated that our Current prophylaxis regimen could be improved.
引用
收藏
页码:266 / 275
页数:10
相关论文
共 50 条
  • [1] The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
    Samara, Evangelia
    Stamatiou, Konstantinos
    Balanika, Marina
    Tzimas, Petros
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [2] How to interpret a prolonged prothrombin time or activated partial thromboplastin time
    Desborough, Michael J.
    Keeling, David M.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (01) : C10 - C12
  • [3] Influence of Preanalytical Variables on Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen
    Kim, Hyunjung
    Kim, Yonggoo
    Lee, Hae Kyung
    CLINICAL LABORATORY, 2015, 61 (09) : 1337 - 1340
  • [4] Genetic Associations for Activated Partial Thromboplastin Time and Prothrombin Time, their Gene Expression Profiles, and Risk of Coronary Artery Disease
    Tang, Weihong
    Schwienbacher, Christine
    Lopez, Lorna M.
    Ben-Shlomo, Yoav
    Oudot-Mellakh, Tiphaine
    Johnson, Andrew D.
    Samani, Nilesh J.
    Basu, Saonli
    Goegele, Martin
    Davies, Gail
    Lowe, Gordon D. O.
    Tregouet, David-Alexandre
    Tan, Adrian
    Pankow, James S.
    Tenesa, Albert
    Levy, Daniel
    Volpato, Claudia B.
    Rumley, Ann
    Gow, Alan J.
    Minelli, Cosetta
    Yarnell, John W. G.
    Porteous, David J.
    Starr, John M.
    Gallacher, John
    Boerwinkle, Eric
    Visscher, Peter M.
    Pramstaller, Peter P.
    Cushman, Mary
    Emilsson, Valur
    Plump, Andrew S.
    Matijevic, Nena
    Morange, Pierre-Emmanuel
    Deary, Ian J.
    Hicks, Andrew A.
    Folsom, Aaron R.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2012, 91 (01) : 152 - 162
  • [5] Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease
    Raffini, Leslie J.
    Niebanck, Alison E.
    Hrusovsky, Joanne
    Stevens, Amanda
    Blackwood-Chirchir, Anne
    Ohene-Frempong, Kwaku
    Kwiatkowski, Janet L.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (05) : 589 - 593
  • [6] Effect of Pre-analytical Conditions on Prothrombin Time and Partial Activated Thromboplastin Time
    Beatriz, Moutinho
    Beatriz, Pinto
    Rita, Cardoso
    Helena, Alves
    Monica, Botelho
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2019, 20 (04) : 327 - 331
  • [7] Prothrombin time, activated partial thromboplastin time and fibrinogen values in Mediterranean marine teleosts
    Pavlidis, M
    Berry, M
    Kokkari, C
    Kentouri, M
    FISH PHYSIOLOGY AND BIOCHEMISTRY, 1999, 21 (04) : 335 - 343
  • [8] Alterations in prothrombin time and activated partial thromboplastin time in patients with acute myocardial infarction
    Khan, Haseeb A.
    Alhomida, Abdullah S.
    Al Rammah, Tamader Y.
    Sobki, Samia H.
    Ola, Mohammad S.
    Khan, Adnan A.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 6 (04): : 294 - 297
  • [9] Prothrombin time, activated partial thromboplastin time and fibrinogen values in Mediterranean marine teleosts
    M. Pavlidis
    M. Berry
    C. Kokkari
    M. Kentouri
    Fish Physiology and Biochemistry, 1999, 21 : 335 - 343
  • [10] Prothrombin Time and Partial Thromboplastin Time Assay Considerations
    Ng, Valerie L.
    CLINICS IN LABORATORY MEDICINE, 2009, 29 (02) : 253 - +